SCHEMBL8936017

SCHEMBL8936017

O=C(O)c1c(CO)no[n+]1[O-]

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CATSPER1 Q8NEC5 2/20 0.39
CA12 O43570 2/20 0.38
CA2 P00918 2/20 0.38
CA9 Q16790 2/20 0.38
TBXA2R P21731 1/20 0.36
CA1 P00915 1/20 0.35
MAPT P10636 4/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
MAPK1 P28482 3/20 0.34
HTT P42858 3/20 0.34
LMNA P02545 2/20 0.34
TP53 P04637 2/20 0.34
PTPN7 P35236 2/20 0.34
HSD17B10 Q99714 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ABCB1 P08183 2/20 0.34
ABCC1 P33527 2/20 0.34
GLA P06280 1/20 0.34
RAB9A P51151 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8936076 0.79 GLA (0.44) CA12CA2CA9CA1MAPT
SCHEMBL11150237 0.72 CATSPER1 (0.50) CATSPER1CA12CA2CA9CA1
SCHEMBL3779883 0.71
SCHEMBL8785232 0.69 CA12 (0.37) CA12CA2CA9TBXA2RCA1
SCHEMBL8785818 0.68 GLA (0.38) CA12CA2CA9TBXA2RCA1
SCHEMBL31094691 0.68 GLA (0.48) CA12CA2CA9CA1MAPT
SCHEMBL32691206 0.62 CATSPER1 (0.40) CATSPER1CA12CA2CA9MAPT
SCHEMBL2207623 0.61 MAPT (0.45) CATSPER1CA12CA2CA9CA1
SCHEMBL11419688 0.60 MAPT (0.47) CATSPER1MAPTALDH1A1HPGDMAPK1
SCHEMBL9213055 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1119013-A Hydroxymethyl furazan carboxylic acid derivatives and their use in the treatment of cardiovascular disease CASSELLA FARBWERKE MAINKUR AG (DE) 1996-03-20 CN disclosed
US-5486531-A ANGINA, HYPOTENSIVE AGENTS, ERECTILE DYSFUNCTION CASSELLA AKTIENGESELLSCHAFT (DE) 1996-01-23 US disclosed